Enabling blockchain for Saudi Arabia drug supply chain using Internet of Things (IoT)
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Blockchain and IoT integration can enhance drug supply chain traceability and reliability. This technology ensures secure, transparent, and efficient distribution of medicines, improving public health outcomes.
Area Of Science
- Pharmaceutical Sciences
- Computer Science
- Public Health
Background
- Drug supply chain inefficiencies and lack of traceability lead to medicine unavailability and compromised public health.
- Current systems struggle with information loss, inadequate tracking of medicinal storage, and poor transparency among stakeholders.
- Conflicting interests among supply chain parties can hinder equitable drug distribution.
Purpose Of The Study
- To propose a novel model for a reliable drug supply chain using blockchain and IoT technologies.
- To address challenges in drug traceability, information sharing, and medicinal storage.
- To enhance the security, transparency, and cost-efficiency of pharmaceutical distribution.
Main Methods
- Development of a token-based blockchain model for decentralized drug traceability.
- Integration of Internet of Things (IoT) devices for continuous data supply and system monitoring.
- Leveraging blockchain's inherent data integrity and provenance features for supply chain management.
Main Results
- The proposed model offers a decentralized and transparent ledger for drug supply chain transactions.
- IoT devices ensure real-time, trustworthy data input, enhancing system reliability.
- Blockchain technology provides robust data integrity and provenance tracking for pharmaceuticals.
Conclusions
- A token-based blockchain system integrated with IoT offers a secure, cost-efficient, and reliable solution for drug supply chain management.
- This approach significantly improves drug traceability, addressing critical public health concerns.
- Decentralized information and enhanced data integrity are key benefits for pharmaceutical distribution.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...